Literature DB >> 12491079

Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis.

Pentti Sipponen1, Pelayo Correa.   

Abstract

BACKGROUND: The age-standardized and cumulative incidence rates of gastric cancer (GCA) are twice as high in males as in females.
METHODS: Based on age-group-specific (5-year age groups) annual incidence data of GCA among males and females published by 18 cancer registries worldwide, and on a consecutive series of 938 GCAs from Finland, we explored how the male predominance of GCA has changed over the decades and how this male predominance may possibly vary worldwide between populations with high and low gastric cancer incidence.
RESULTS: It appeared that the age-group-specific male-to-female (M/F) ratio of the annual GCA incidence is not constant but increases with age, reaches a peak at age around 60, and decreases thereafter. This special form of the M/F curve is not seen in other gastrointestinal (GI) cancer types (colon, rectum, pancreas). This "low-high-low" form of the M/F curve is related to a 10- to 15-year delay in the appearance and onset of GCA of the intestinal type in females compared with males. The age-group-specific M/F ratio rises as the GCA of the intestinal subtype prevails in males and is rare in females before age 60 and starts to decrease after age 60 as the GCA of the intestinal subtype begins to be common also in females. This special form of the M/F curve is globally consistent and similar in countries or populations of high and low GCA incidence. The data from the Finnish Cancer Registry indicate that the age group-specific M/F curve of the annual GCA incidence has, in addition, remained unchanged over the decades (from the 1950s) in spite of a decrease in the annual GCA incidence of more than 70%. In order to examine the role of gastritis-related diseases as a cause of the sex difference in GCA, 1700 consecutive endoscopied outpatients were studied in Finland. In this series, the age-group-specific prevalences of Helicobacter pylori gastritis, atrophic gastritis, or intestinal metaplasia were proportionally as common in males as in females in all age groups except for the youngest one (20-49 years), in which H. pylori nonatrophic gastritis was slightly more common in males than in females.
CONCLUSION: The male predominance of GCA is a global phenomenon, and is similar in populations with high and low GCA incidence, and this predominance is related to a 10- to 15-year delay in the appearance and onset of GCA of the intestinal subtype in females compared with males. It is suggested that sex hormones (estrogens) protect women against GCA, and that GCA begins to be as prevalent in females as in males only after the menopausal age. Another possibility is that a later acquisition of H. pylori gastritis in females than in males causes the relative delay in the appearance and onset of new GCA cases in females compared with males.

Entities:  

Mesh:

Year:  2002        PMID: 12491079     DOI: 10.1007/s101200200037

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  65 in total

1.  Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.

Authors:  Neal D Freedman; Jiyoung Ahn; Lifang Hou; Jolanta Lissowska; Witold Zatonski; Meredith Yeager; Stephen J Chanock; Wong Ho Chow; Christian C Abnet
Journal:  Carcinogenesis       Date:  2008-11-17       Impact factor: 4.944

2.  Correlation of Helicobacter pylori and interleukin-8 mRNA expression in high risk gastric cancer population prediction.

Authors:  Wilaiwan Chongruksut; Sirikan Limpakan Yamada; Bandhuphat Chakrabandhu; Chidchanok Ruengorn; Sirisak Nanta
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

3.  17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice.

Authors:  Masahiro Ohtani; Zhongming Ge; Alexis García; Arlin B Rogers; Sureshkumar Muthupalani; Nancy S Taylor; Shilu Xu; Koichiro Watanabe; Yan Feng; Robert P Marini; Mark T Whary; Timothy C Wang; James G Fox
Journal:  Carcinogenesis       Date:  2011-05-11       Impact factor: 4.944

4.  Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach.

Authors:  Kyoung-Joo Kwon; Ki-Nam Shim; Eun-Mi Song; Ju-Young Choi; Seong-Eun Kim; Hye-Kyung Jung; Sung-Ae Jung
Journal:  Gastric Cancer       Date:  2013-02-07       Impact factor: 7.370

5.  The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells.

Authors:  Jian Qin; Min Liu; Qianshan Ding; Xiang Ji; Yarong Hao; Xiaomin Wu; Jie Xiong
Journal:  Mol Cell Biochem       Date:  2014-06-17       Impact factor: 3.396

6.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

Authors:  Gwen Murphy; Ruth Pfeiffer; M Constanza Camargo; Charles S Rabkin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

7.  Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.

Authors:  Melina Arnold; Amy Colquhoun; Michael B Cook; Jacques Ferlay; David Forman; Isabelle Soerjomataram
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

8.  Age and sex interactions in gastric cancer incidence and mortality trends in Korea.

Authors:  Minkyo Song; Daehee Kang; Jae Jeong Yang; Ji-Yeob Choi; Hyuna Sung; Yunhee Lee; Hyung-Suk Yoon; Yunhee Choi; Seong-Ho Kong; Hyuk-Joon Lee; Han-Kwang Yang; Woo Ho Kim
Journal:  Gastric Cancer       Date:  2014-08-05       Impact factor: 7.370

9.  Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma.

Authors:  Evangelos Chandanos; Carlos A Rubio; Mats Lindblad; Chongqi Jia; Apostolos V Tsolakis; Margaret Warner; Jan-Ake Gustafsson; Jesper Lagergren
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

10.  Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium.

Authors:  Chang Mo Moon; Seok-Hyung Kim; Sang Kil Lee; Jiyeon Hyeon; Ja Seung Koo; Sangheun Lee; Jean S Wang; Won Jae Huh; Shradha S Khurana; Jason C Mills
Journal:  Dig Dis Sci       Date:  2013-12-25       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.